Vivo Capital Names John Massad Managing Director, Business Development

PALO ALTO, Calif.--(BUSINESS WIRE)-- Vivo Capital, LLC, a leading global healthcare investment firm, is pleased to announce that John A. Massad, CFA has joined the firm as Managing Director, Business Development.

Mr. Massad has more than two decades of business development and investor relations experience, including serving as Highbridge Capital Management’s (a JP Morgan Chase company) Global Head of Business Development and Investor Relations. Prior to this, he held business development leadership roles at KKR, Caxton Associates, BlackRock, and JP Morgan. Mr. Massad began his career in investment banking at JP Morgan. He earned an M.B.A. from Cornell University and a B.S.E. in Mechanical and Aerospace Engineering from Princeton University.

Dr. Frank Kung, Co-Founder, Managing Partner, and Chairman of Vivo, said: “We are excited to have John join our team. His strong investment acumen, innovative approach to business-building and extensive experience working with pensions, endowments, foundations, insurance companies, investment consultants, wealth management platforms, and other investors in the US and globally make him an ideal choice to support Vivo’s continued growth momentum. We are confident that his experience and his proven ability to forge strong relationships will make him a great addition to our team and an equally strong partner to all our clients.”

About Vivo Capital

Founded in 1996, Vivo Capital is a leading global healthcare investment firm with a diverse, multi-fund investment platform in venture capital, growth equity, buyout, and public equities. The Firm has approximately $6.4 billion in assets under management and has invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with additional offices in Asia, the Vivo team consists of more than 50 multi-disciplinary professionals. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005433/en/

[email protected]
650-688-0818

Source: Vivo Capital, LLC

You May Also Be Interested In

• Penguin Solutions Expands ClusterWareAI Operating System Software for AI Factories with AI-Powered Operations and Automated Remediation
• Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
• Bold Ventures Intersects 100.7 g/t Gold over 2.95 Meters at Traxxin Main Zone - Expands East Side Potential